Beyond, Inc. SEC Filings

Bed Bath & Beyond, Inc. is registering shares to acquire The Brand House Collective (TBHC) in an all‑stock merger. TBHC will merge into a Bed Bath & Beyond subsidiary and become a wholly owned subsidiary of Bed Bath & Beyond.

Each share of TBHC common stock will be converted into 0.1993 shares of Bed Bath & Beyond common stock, plus cash instead of fractional shares. Using Bed Bath & Beyond’s November 21, 2025 NYSE closing price of $5.56, this implied about $1.11 of value per TBHC share at signing, though the actual value will move with Bed Bath & Beyond’s share price.

TBHC’s board unanimously recommends shareholders vote for the merger, an advisory vote on merger‑related executive compensation, and a possible adjournment to solicit more proxies. If completed, former TBHC holders are expected to own about 4.2% of the combined company, which will continue to trade on the NYSE under “BBBY,” while TBHC will be delisted from Nasdaq. If the deal fails under specified circumstances, TBHC may owe Bed Bath & Beyond a $1.0 million termination fee and a $0.3 million expense reimbursement.

Bed Bath & Beyond, Inc. reported a leadership change at the top of the company. The Board appointed Marcus Lemonis, currently Executive Chairman and the company’s principal executive officer, as Chief Executive Officer, effective January 1, 2026. He will continue to serve as Executive Chairman and principal executive officer, consolidating the company’s senior leadership roles under one individual. The company plans to enter into an employment agreement with Mr. Lemonis, with key terms to be disclosed in a later filing.

The company also ended the employment of Alexander Thomas, its Chief Operating Officer and principal operating officer, as of the same effective date. Mr. Thomas is expected to act as an advisor for a transition period after January 1, 2026 to support an orderly handover of his responsibilities.

Bed Bath & Beyond, Inc. reported that on November 25, 2025 it purchased, via a participation agreement, a portion of loans issued by The Container Store, Inc. under a term loan credit agreement originally dated January 28, 2025 and amended on September 15, 2025. The aggregate purchase price for the company’s participation in these loans was $6,461,843.09.

Through this participation, Bed Bath & Beyond will share in the right to receive interest and principal payments on the loans, as well as in any exercise of rights or remedies related to those loans.

Bed Bath & Beyond (BBBY)116,686 restricted stock units (RSUs) of Bed Bath & Beyond common stock at a price of $0 per unit.

Each RSU represents a contingent right to receive one share of common stock. The award vests in three equal installments at the close of business on November 3, 2026, November 3, 2027 and November 3, 2028, with vested shares to be delivered to the executive promptly after each vesting date. Following this grant, the executive holds 116,686 derivative securities directly.

Bed Bath & Beyond, Inc. (BBBY) reported that one of its executives, serving as Executive Vice President, Chief Digital, Product, and Technology Officer, filed an initial ownership report on Form 3 as of 11/14/2025. The filing states that this officer currently does not beneficially own any Bed Bath & Beyond securities, and both the non-derivative and derivative ownership tables show no reported holdings.

Bed Bath & Beyond (BBBY) Chief Accounting Officer, who files individually, reported equity award activity and a warrant distribution. On 11/15/2025, the officer acquired 1,186 shares of common stock at an exercise price of $0.0001 through the vesting and settlement of restricted stock units, and disposed of 289 shares at $6.03, typically reflecting shares withheld or sold to cover taxes. Following these transactions, the officer directly holds 3,077 shares of common stock.

In the derivative table, the officer shows 26,906 restricted stock units beneficially owned after the reported RSU conversion, each representing one share of common stock, vesting in two equal installments on November 15, 2025 and November 15, 2026. The officer also acquired 218 common stock warrants with a $15.50 exercise price from an October 7, 2025 pro-rata distribution to all common shareholders, which become exercisable once an S-3 registration statement for the warrant shares is declared effective and remain exercisable through October 7, 2026.

Bed Bath & Beyond Inc.'s Chief Operating Officer reported equity transactions reflecting routine compensation activity. On 11/15/2025, 1,186 shares of common stock were acquired upon the vesting and settlement of restricted stock units at an exercise price of $0.0001 per share, and 343 shares were disposed of at $6.03 per share, typically consistent with tax withholding. Following these transactions, the reporting person directly owned 8,793 common shares and indirectly held 66 shares through a 401(k) plan balance as of 11/17/2025.

In the derivative table, 1,186 restricted stock units converted into common stock, leaving 43,143 derivative securities reported as beneficially owned. The filing also lists 794 common stock warrants with an exercise price of $15.50 per share, originally issued on 10/07/2025 as a pro-rata distribution. These warrants will become exercisable once a Form S-3 registering the underlying shares is declared effective by the SEC and may be exercised through 10/07/2026.

Bed Bath & Beyond Inc. (BBBY): A series of the Amplify ETF Trust filed a Schedule 13G reporting beneficial ownership of 4,496,275 shares of BBBY common stock, representing 6.53% of the class as of 09/30/2025.

The filer reports sole voting power over 4,496,275 shares and sole dispositive power over 4,496,275 shares, with no shared voting or dispositive power. The filing identifies the filer as an investment company registered under section 8 of the Investment Company Act of 1940.

The filing notes the fund’s clients have the right to receive or direct the receipt of dividends or sale proceeds from the reported securities, and that no one other person’s interest exceeds 5%.

Bed Bath & Beyond, Inc. announced the adoption of its 2025 Employment Inducement Equity Incentive Plan. The plan reserves a maximum of 1,500,000 shares of common stock for equity-based awards.

Adopted without stockholder approval under NYSE Rule 303A.08, the plan permits non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants may be made only as “employment inducement” awards and must be approved by a majority of Independent Directors or the Compensation Committee composed solely of Independent Directors.